Is Testosterone About to Be De-Scheduled? What the FDA Panel Could Mean for TRT

Testosterone is the only natural hormone treated like a street drug—and the FDA just signaled that could change.

In this episode, Amy Stuttle sits down with Rick Collins, Esq. (“Legal Muscle”)—one of the most well-known attorneys in the hormone, supplement, and peptide space—to break down the recent FDA expert panel on testosterone in men and what it could mean for patients, prescribers, and the industry.

You’ll hear them unpack:

• Why experts are pushing to de-schedule testosterone (currently Schedule III)
• The argument that low T is a health crisis, not “vanity”
• Why the panelists want the prostate cancer warning stripped and the outdated narrative retired
• The ongoing shift on cardiovascular risk, including the FDA’s removal of the black box warning and discussion of the TRAVERSE trial
• The reality that most prescribing is effectively off-label under today’s criteria—and why that may change
• A candid breakdown of the “research use only” peptide crackdown, why over-regulation fuels black markets, and where legitimate medical oversight fits in

 

Follow Rick on Instagram at @RickCollinsESQ for updates as this story develops.

 

Rick Collins Instagram Click Here

Victory Men's Health Click Here
Victory Men's Health YouTube
For questions email podcast@amystuttle.com

Disclaimer: The Women Want Strong Men Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional healthcare services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user’s own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.